1 |
WHO. Coronavirus Disease (COVID-19) Dashboard [EB/OL]. [2021-02-21]. Data last updated: 04: 21pm CEST.
URL
|
2 |
Grasselli G, Greco M, Zanella A, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy [J]. JAMA Intern Med, 2020, 180(10): 1345-1355.
|
3 |
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [J]. Lancet Respir Med, 2020, 8(5): 475-481.
|
4 |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 2020, 395(10223): 497-506.
|
5 |
Guerin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome [J]. N Engl J Med, 2013, 368(23): 2159-2168.
|
6 |
Ding L, Wang L, Ma W, et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study [J]. Crit Care, 2020, 24(1): 28.
|
7 |
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [J]. Lancet Respir Med, 2020, 8(4): 420-422.
|
8 |
Xu Q, Wang T, Qin X, et al. Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series [J]. Crit Care, 2020, 24(1): 250.
|
9 |
Teng XB, Shen Y, Han MF, et al. The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia [J]. Eur J Clin Invest, 2021, 51(3): e13435.
|
10 |
Ferrando C, Mellado-Artigas R, Gea A, et al. Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study [J]. Crit Care, 2020, 24(1): 597.
|
11 |
Xie J, Tong Z, Guan X, et al. Critical care crisis and some recommendations during the COVID-19 epidemic in China [J]. Intensive Care Med, 2020, 46(5): 837-840.
|
12 |
Al-Samkari H, Karp LR, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection [J]. Blood, 2020, 136(4): 489-500.
|
13 |
Kox M, Waalders NJB, Kooistra EJ, et al. Cytokine levels in critically ill patients with COVID-19 and other conditions [J]. JAMA, 2020, 324(15): 1565-1567.
|
14 |
刘茜, 王荣帅, 屈国强, 等. 新型冠状病毒肺炎死亡尸体系统解剖大体观察报告 [J]. 法医学杂志, 2020, 36(1): 21-23.
|
15 |
Despres C, Brunin Y, Berthier F, et al. Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe COVID-19 patients [J]. Crit Care, 2020, 24(1): 256.
|
16 |
Bower G, He H. Protocol for awake prone positioning in COVID-19 patients: to do it earlier, easier, and longer [J]. Crit Care, 2020, 24(1): 371.
|
17 |
Tan W, Xu DY, Xu MJ, et al. The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis [J]. Ther Adv Respir Dis, 2021, 15: 1631378561.
|
18 |
Stilma W, Åkerman E, Artigas A, et al. Awake proning as an adjunctive therapy for refractory hypoxemia in non-intubated patients with COVID-19 acute respiratory failure: guidance from an International Group of Healthcare Workers [J]. Am J Trop Med Hyg, 2021, 104(5): 1676-1686.
|
19 |
Siemieniuk R, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline [J]. BMJ, 2018, 363: k4169.
|
20 |
北京协和医院新型冠状病毒感染的肺炎诊治专家组. 北京协和医院关于"新型冠状病毒感染的肺炎"诊疗建议方案(V2.0) [J]. 中华内科杂志, 2020, 59(3): 186-188.
|
21 |
倪忠, 秦浩, 李洁, 等. 新型冠状病毒肺炎患者经鼻高流量氧疗使用管理专家共识 [J]. 中国呼吸与危重监护杂志, 2020, 19(2): 110-115.
|
22 |
Moller W, Feng S, Domanski U, et al. Nasal high flow reduces dead space [J]. J Appl Physiol (1985), 2017, 122(1): 191-197.
|
23 |
Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy [J]. Am J Respir Crit Care Med, 2019, 199(11): 1368-1376.
|
24 |
郑瑞强, 胡明, 李绪言, 等. 重症新型冠状病毒肺炎呼吸治疗流程专家建议 [J/OL]. 中华重症医学电子杂志, 2020, 6(1): 15-18.
|